88 results
8-K
EX-99.1
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:22am
and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. In the third quarter
8-K
EX-99.1
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
7:18am
investment in Verona Pharma underscores Oaktree’s commitment to provide flexible capital solutions to innovative life sciences companies … is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet
8-K
EX-99.1
ekn39s7y9y 28gcy
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
8-K
EX-99.1
5k7izwz9ixcimlxr
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-99.1
6c202
2 Nov 23
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:24am
8-K
EX-99.1
r4bem73m148xw xuk
3 Aug 23
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:11am
8-K
EX-99.1
8r1h9yd6m
9 May 23
Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
6:13am
8-K
EX-99.1
jpm111zk50rf
9 Nov 22
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
6:35am
424B5
v7qiq
11 Aug 22
Prospectus supplement for primary offering
5:09pm
8-K
EX-99.1
n3fcxfcg
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
424B5
x5jv5 k6jyzmni8ew5n5
9 Aug 22
Prospectus supplement for primary offering
12:00am